Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.769
-0.031 (-3.88%)
At close: Dec 5, 2025
Avenue Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 3.71 | 2.59 | 1.78 | 6.71 | 3.76 | 3.13 | Upgrade
|
| Cash & Short-Term Investments | 3.71 | 2.59 | 1.78 | 6.71 | 3.76 | 3.13 | Upgrade
|
| Cash Growth | 42.82% | 45.48% | -73.42% | 78.26% | 20.15% | -64.19% | Upgrade
|
| Other Receivables | - | - | - | - | 0.09 | - | Upgrade
|
| Receivables | - | - | - | - | 0.09 | - | Upgrade
|
| Prepaid Expenses | 0.02 | 0.08 | 0.07 | 0.14 | 0.11 | 0.11 | Upgrade
|
| Total Current Assets | 3.73 | 2.67 | 1.85 | 6.85 | 3.96 | 3.25 | Upgrade
|
| Total Assets | 3.73 | 2.67 | 1.85 | 6.85 | 3.96 | 3.25 | Upgrade
|
| Accounts Payable | 1.03 | 0.3 | 0.4 | 0.15 | 0.36 | 0.17 | Upgrade
|
| Accrued Expenses | 0.39 | 0.5 | 0.21 | 0.82 | 0.15 | 0.71 | Upgrade
|
| Other Current Liabilities | 0 | 0.02 | 0.59 | 2.61 | - | - | Upgrade
|
| Total Current Liabilities | 1.42 | 0.82 | 1.2 | 3.58 | 0.51 | 0.89 | Upgrade
|
| Total Liabilities | 1.42 | 0.82 | 1.2 | 3.58 | 0.51 | 0.89 | Upgrade
|
| Common Stock | - | - | 0 | - | - | 0 | Upgrade
|
| Additional Paid-In Capital | 108.34 | 105.38 | 92.51 | 84.46 | 80.45 | 75.63 | Upgrade
|
| Retained Earnings | -104.78 | -102.58 | -90.93 | -80.55 | -77 | -73.27 | Upgrade
|
| Total Common Equity | 3.56 | 2.8 | 1.58 | 3.91 | 3.45 | 2.36 | Upgrade
|
| Minority Interest | -1.25 | -0.94 | -0.93 | -0.64 | - | - | Upgrade
|
| Shareholders' Equity | 2.3 | 1.86 | 0.65 | 3.27 | 3.45 | 2.36 | Upgrade
|
| Total Liabilities & Equity | 3.73 | 2.67 | 1.85 | 6.85 | 3.96 | 3.25 | Upgrade
|
| Net Cash (Debt) | 3.71 | 2.59 | 1.78 | 6.71 | 3.76 | 3.13 | Upgrade
|
| Net Cash Growth | 42.82% | 45.48% | -73.42% | 78.26% | 20.15% | -64.19% | Upgrade
|
| Net Cash Per Share | 1.32 | 2.00 | 12.63 | 230.24 | 249.06 | 213.47 | Upgrade
|
| Filing Date Shares Outstanding | 3.18 | 3.15 | 0.59 | 0.08 | 0.02 | 0.01 | Upgrade
|
| Total Common Shares Outstanding | 3.18 | 2.11 | 0.34 | 0.06 | 0.02 | 0.01 | Upgrade
|
| Working Capital | 2.3 | 1.86 | 0.65 | 3.27 | 3.45 | 2.36 | Upgrade
|
| Book Value Per Share | 1.12 | 1.33 | 4.64 | 61.35 | 184.09 | 158.46 | Upgrade
|
| Tangible Book Value | 3.56 | 2.8 | 1.58 | 3.91 | 3.45 | 2.36 | Upgrade
|
| Tangible Book Value Per Share | 1.12 | 1.33 | 4.64 | 61.35 | 184.09 | 158.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.